RGC logo

Regencell Bioscience Holdings Limited (RGC) EBIT

Annual EBIT

-$4.74 M
+$1.54 M+24.50%

01 June 2024

RGC EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGC EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.5%--
3 y3 years-242.9%--
5 y5 years-1111.4%--

RGC EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-242.9%+37.8%
5 y5 years-1111.4%+37.8%
alltimeall time-1111.4%+37.8%

Regencell Bioscience Holdings Limited EBIT History

DateAnnualQuarterlyTTM
June 2024
-$4.74 M(-24.5%)
-
-
June 2023
-$6.27 M(-17.6%)
-
-
June 2022
-$7.62 M(+451.5%)
-
-
DateAnnualQuarterlyTTM
June 2021
-$1.38 M(+70.0%)
-
-
June 2020
-$812.40 K(+107.8%)
-
-
June 2019
-$391.00 K
-
-

FAQ

  • What is Regencell Bioscience Holdings Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Regencell Bioscience Holdings Limited?
  • What is Regencell Bioscience Holdings Limited annual EBIT year-on-year change?

What is Regencell Bioscience Holdings Limited annual earnings before interest & taxes?

The current annual EBIT of RGC is -$4.74 M

What is the all time high annual EBIT for Regencell Bioscience Holdings Limited?

Regencell Bioscience Holdings Limited all-time high annual earnings before interest & taxes is -$391.00 K

What is Regencell Bioscience Holdings Limited annual EBIT year-on-year change?

Over the past year, RGC annual earnings before interest & taxes has changed by +$1.54 M (+24.50%)